TECH

BIO-TECHNE CORP

Healthcare | Mid Cap

$0.51

EPS Forecast

$318.8

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

$0.51

Revenue Forecast:

$318.8

EPS Surprise Forecast:

$0.032

Revenue Surprise Forecast:

-$1

Post-release price volatility - High

Post-release Overnight Move:

±7.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

71%

Probability of beating revenue consensus:

48%

Probability of beating both EPS & revs consensus:

40%

Probability of missing both EPS & revs consensus:

21%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

0.88

Earnings volatility

EPS standard deviation:

$0.15

Revenue standard deviation:

$17

As % of share price:

0.29% MEDIUM

As % of market cap:

0.21% LOW

Confidence intervals and percentiles

EPS 95th %ile:

$0.71

Revenue 95th %ile:

$342

EPS 75th %ile:

$0.56

Revenue 75th %ile:

$325

EPS 25th %ile:

$0.47

Revenue 25th %ile:

$314

EPS 5th %ile:

$0.35

Revenue 5th %ile:

$300

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

62% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$10

Bid-ask per Share:

$0.05